Rick Doblin, PhD, Weighs in on the FDA CRL for MDMA-Assisted TherapyByRick Doblin, PhDSeptember 24th 2025Rick Doblin discusses FDA's recent feedback on MDMA-assisted therapy for PTSD, emphasizing transparency and the therapy's potential in clinical practice.